The DOI matches its Crossref record; 165 of the 165 references it cites were found in a registry or an index.
Cellular pathology of Parkinson?s disease: astrocytes, microglia and inflammation
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1982) · Trends in Neurosciences · doi:10.1016/0166-2236(82)90076-5 · Cited by 9,089
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382 · cited 2×
“1998) and is a major component of Lewy bodies (Polymeropoulos et al. 1997; Spillantini et al. 1997; Baba et al. 1998), is also nitrated in the MPTP-model as well as in PD (Giasson et al.”
BackgroundMutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240 · cited 1×
“…caused by oxidative damage. α-Synuclein, which has been linked to autosomal dominant PD (Kruger et al. 1998) and is a major component of Lewy bodies (Polymeropoulos et al. 1997; Spillantini et al. 1997; Baba et al. 1998), is also nitrated in the MPTP-model as well as in PD (Giasson et al. 2000;…”
BackgroundDauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
Microglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
Primate models of movement disorders of basal ganglia origin
DeLong, M. R. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90110-v · Cited by 3,824
Missing Pieces in the NF-κB Puzzle
Ghosh, S., & Karin, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00703-1 · Cited by 3,638 · cited 1×
“NF-κB translocates to the nucleus by elimination of inhibitory protein κ-Bα (IκBα) due to phosphorylation (Nomura 2001; Ghosh and Karin 2002) where it activates the apoptotic machinery.”
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
Babior, B. M. (1999) · Blood · doi:10.1182/blood.v93.5.1464 · Cited by 2,134
Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain
Lawson, L. J., Perry, V. H., Dri, P., & Gordon, S. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90229-w · Cited by 2,045 · cited 1×
“The SN is relatively rich in microglia compared with other brain regions (Lawson et al. 1990; Kim et al. 2000).”
BackgroundUngerstedt, U., & Arbuthnott, G. W. (1970) · Brain Research · doi:10.1016/0006-8993(70)90187-3 · Cited by 1,978
Handbook of Experimental Pharmacology.
Meakin, J. W. (1971) · Archives of Internal Medicine · doi:10.1001/archinte.1971.00310230151026 · Cited by 1,959
Ungerstedt, U. (1971) · Acta Physiologica Scandinavica · doi:10.1111/j.1365-201x.1971.tb11000.x · Cited by 1,922
Kujubu, D. A., Fletcher, B. S., Varnum, B. C., Lim, R. W., & Herschman, H. R. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98774-0 · Cited by 1,789
Regulation of biosynthesis of nitric oxide.
Nathan, C., & Xie, Q. W. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36703-0 · Cited by 1,669
(1998) · Europe PMC (PubMed Central) · Cited by 1,594
Giasson, B. I., Duda, J. E., Murray, I. V. J., Chen, Q., Souza, J. M., Hurtig, H. I., Ischiropoulos, H., Trojanowski, J. Q., & -Y. Lee, V. M. (2000) · Science · doi:10.1126/science.290.5493.985 · Cited by 1,546
6-hydroxy-dopamine induced degeneration of central monoamine neurons
Ungerstedt, U. (1968) · European Journal of Pharmacology · doi:10.1016/0014-2999(68)90164-7 · Cited by 1,460
Molecular profile of reactive astrocytes—Implications for their role in neurologic disease
Eddleston, M., & Mucke, L. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90380-x · Cited by 1,431
α-Synuclein Is Degraded by Both Autophagy and the Proteasome
Webb, J. L., Ravikumar, B., Atkins, J., Skepper, J. N., & Rubinsztein, D. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300227200 · Cited by 1,429
Direct brain infusion of glial cell line–derived neurotrophic factor in Parkinson disease
Gill, S. S., Patel, N. K., Hotton, G. R., O'Sullivan, K., McCarter, R., Bunnage, M., Brooks, D. J., Svendsen, C. N., & Heywood, P. (2003) · Nature Medicine · doi:10.1038/nm850 · Cited by 1,290
Kordower, J. H., Emborg, M. E., Bloch, J., Ma, S. Y., Chu, Y., Leventhal, L., McBride, J., Chen, E.-Y., Palfi, S., Roitberg, B. Z., et al. (2000) · Science · doi:10.1126/science.290.5492.767 · Cited by 1,251
Glutathione, oxidative stress and neurodegeneration
Schulz, J. B., Lindenau, J., Seyfried, J., & Dichgans, J. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01595.x · Cited by 1,213
Self-citationGreen, D. R. (1998) · Cell · doi:10.1016/s0092-8674(00)81728-6 · Cited by 1,196
Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease.
Anglade, P., Vyas, S., Javoy-Agid, F., Herrero, M. T., Michel, P. P., Marquez, J., Prigent, A., Ruberg, M., Hirsch, É. C., & Agid, Y. (1997) · PubMed · Cited by 1,188
Microglia: Intrinsic immuneffector cell of the brain
Gehrmann, J., Matsumoto, Y., & Kreutzberg, G. W. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(94)00015-h · Cited by 1,119
Liberatore, G. T., Jackson-Lewis, V., Vukosavic, S., Mandir, A. S., Vila, M., McAuliffe, W. G., Dawson, V. L., Dawson, T. M., & Przedborski, S. (1999) · Nature Medicine · doi:10.1038/70978 · Cited by 1,046 · cited 4×
“…astrocytic activation parallels the time course of dopaminergic cell death in the SNpc as well as striatum and GFAP-expression remains upregulated even after most of dopaminergic neurons have died due to MPTP intoxication (Czlonkowska et al. 1996; Kohutnicka et al. 1998; Liberatore et al. 1999).”
BackgroundInfluentialBanati, R. B., Gehrmann, J., Schubert, P., & Kreutzberg, G. W. (1993) · Glia · doi:10.1002/glia.440070117 · Cited by 1,029
Mogi, M., Harada, M., Riederer, P., Narabayashi, H., Fujita, K., & Nagatsu, T. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90746-3 · Cited by 986
Functional recovery in parkinsonian monkeys treated with GDNF
Gash, D. M., Zhang, Z., Ovadia, A., Cass, W. A., Yi, A., Simmerman, L., Russell, D., Martin, D., Lapchak, P. A., Collins, F., et al. (1996) · Nature · doi:10.1038/380252a0 · Cited by 955
The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it
Fahn, S., & Cohen, G. (1992) · Annals of Neurology · doi:10.1002/ana.410320616 · Cited by 927
Striatal Dopamine Release after Amphetamine or Nerve Degeneration Revealed by Rotational Behaviour
Ungerstedt, U. (1971) · Acta Physiologica Scandinavica · doi:10.1111/j.1365-201x.1971.tb10999.x · Cited by 923
Kim, W.-G., Mohney, R. P., Wilson, B., Jeohn, G.-H., Liu, B., & Hong, J.-S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-16-06309.2000 · Cited by 878
Sauer, H., & Oertel, W. H. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90605-x · Cited by 803
Rothwell, J. (1982) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.45.5.476 · Cited by 744
Cyclo-Oxygenase-2 Gene Expression in Neurons Contributes to Ischemic Brain Damage
Nogawa, S., Zhang, F., Ross, M. E., & Iadecola, C. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02746.1997 · Cited by 716
Hartmann, A., Hunot, S., Michel, P. P., Muriel, M.-P., Vyas, S., Faucheux, B. A., Mouatt-Prigent, A., Turmel, H., Srinivasan, A., Ruberg, M., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040556597 · Cited by 715
Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages
Xia, Y., & Zweier, J. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6954 · Cited by 691
Hunot, S., Brugg, B., Ricard, D., Michel, P. P., Muriel, M.-P., Ruberg, M., Faucheux, B. A., Agid, Y., & Hirsch, E. C. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7531 · Cited by 678
Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration
Teismann, P., Tieu, K., Choi, D.-K., Wu, D.-C., Naini, A., Hunot, S., Vila, M., Jackson-Lewis, V., & Przedborski, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0837397100 · Cited by 660
Self-citationWu, D.-C., Teismann, P., Tieu, K., Vila, M., Jackson-Lewis, V., Ischiropoulos, H., & Przedborski, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0937239100 · Cited by 633
Self-citationNitric oxide synthase and neuronal vulnerability in parkinson's disease
Hunot, S., Boissière, F., Faucheux, B., Brugg, B., Mouatt-Prigent, A., Agid, Y., & Hirsch, E. C. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00578-1 · Cited by 595
Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease
Boka, G., Anglade, P., Wallach, D., Javoy-Agid, F., Agid, Y., & Hirsch, E. C. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90684-x · Cited by 590
Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization
Giulian, D., Woodward, J., Young, D., Krebs, J., & Lachman, L. (1988) · The Journal of Neuroscience · doi:10.1523/jneurosci.08-07-02485.1988 · Cited by 588
A serum- and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein.
O'Banion, M. K., Sadowski, H. B., Winn, V., & Young, D. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54491-4 · Cited by 557
Changes in cytokines and neurotrophins in Parkinson’s disease
Nagatsu, T., Mogi, M., Ichinose, H., & Togari, A. (2000) · Advances in Research on Neurodegeneration · doi:10.1007/978-3-7091-6301-6_19 · Cited by 510
Inflammatory Regulators in Parkinson's Disease: iNOS, Lipocortin-1, and Cyclooxygenases-1 and -2
Knott, C., Stern, G., & Wilkin, G. P. (2000) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2000.0914 · Cited by 503
Tanaka, Y. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.9.919 · Cited by 497
(2001) · doi:10.1523/jneurosci.21-24-09549.2001 · Cited by 476
Glutathione peroxidase, glial cells and Parkinson's disease
Damier, P., Hirsch, E. C., Zhang, P., Agid, Y., & Javoy-Agid, F. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90175-f · Cited by 466
Spina, M. B., Squinto, S. P., Miller, J., Lindsay, R. M., & Hyman, C. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08880.x · Cited by 460
Przedborski, S., Kostic, V, Jackson-Lewis, V, Naini, A., Simonetti, S., Fahn, S., Carlson, E., Epstein, C., & Cadet, J. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-05-01658.1992 · Cited by 456
Prostaglandin and thromboxane biosynthesis
Smith, W. L., Marnett, L. J., & DeWitt, D. L. (1991) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(91)90054-p · Cited by 442
Tranzer, J. P., & Thoenen, H. (1968) · Experientia · doi:10.1007/bf02146956 · Cited by 442
Wakabayashi, K., Hayashi, S., Yoshimoto, M., Kudo, H., & Takahashi, H. (2000) · Acta Neuropathologica · doi:10.1007/pl00007400 · Cited by 441
Glial pathology but absence of apoptotic nigral neurons in long‐standing Parkinson's disease
Banati, R. B., Daniel, S. E., & Blunt, S. B. (1998) · Movement Disorders · doi:10.1002/mds.870130205 · Cited by 431
Inhibition of neuronal nitric oxide synthase prevents MPTP–induced parkinsonism in baboons
Hantraye, P., Brouillet, E., Ferrante, R., Palfi, S., Dolan, R., Matthews, R. T., & Beal, M. F. (1996) · Nature Medicine · doi:10.1038/nm0996-1017 · Cited by 422
Schulz, J. B., Matthews, R. T., Muqit, M. M. K., Browne, S. E., & Beal, M. F. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64020936.x · Cited by 417
Self-citationHunot, S., Dugas, N., Faucheux, B., Hartmann, A., Tardieu, M., Debré, P., Agid, Y., Dugas, B., & Hirsch, E. C. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-09-03440.1999 · Cited by 408
Cicchetti, F., Brownell, A. L., Williams, K., Chen, Y. I., Livni, E., & Isacson, O. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.01938.x · Cited by 406
Cyclooxygenase-2: Molecular Biology, Pharmacology, and Neurobiology
O'Banion, M. K. (1999) · Critical Reviews in Neurobiology · doi:10.1615/critrevneurobiol.v13.i1.30 · Cited by 404
McGeer, P. L., Schwab, C., Parent, A., & Doudet, D. (2003) · Annals of Neurology · doi:10.1002/ana.10728 · Cited by 400
Dehmer, T., Heneka, M. T., Sastre, M., Dichgans, J., & Schulz, J. B. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02210.x · Cited by 382
Self-citationSriram, K., Matheson, J. M., Benkovic, S. A., Miller, D. B., Luster, M. I., & O'Callaghan, J. P. (2002) · The FASEB Journal · doi:10.1096/fj.02-0216fje · Cited by 362
Enzymatic Oxidation of Dopamine: The Role of Prostaglandin H Synthase
Hastings, T. G. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64020919.x · Cited by 359
Mechanisms of action of 6-hydroxydopamine
Sachs, C., & Jonsson, G. (1975) · Biochemical Pharmacology · doi:10.1016/0006-2952(75)90304-4 · Cited by 357
Locus ceruleus lesions and eosinophilic inclusions in MPTP‐treated monkeys
Forno, L. S., Langston, J. W., DeLanney, L. E., Irwin, I., & Ricaurte, G. A. (1986) · Annals of Neurology · doi:10.1002/ana.410200403 · Cited by 350
Deficiency of Inducible Nitric Oxide Synthase Protects Against MPTP Toxicity In Vivo
Dehmer, T., Lindenau, J., Haid, S., Dichgans, J., & Schulz, J. B. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0742213.x · Cited by 337
Self-citationUltrastructural immunocytochemical localization of tyrosine hydroxylase in the neostriatum
Pickel, V. M., Beckley, S. C., Joh, T. H., & Reis, D. J. (1981) · Brain Research · doi:10.1016/0006-8993(81)90843-x · Cited by 329
Mirza, B., Hadberg, H., Thomsen, P., & Moos, T. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00455-8 · Cited by 327
The role of glial cells in Parkinsonʼs disease
Vila, M., Jackson-Lewis, V., Guégan, C., Chu Wu, D., Teismann, P., Choi, D.-K., Tieu, K., & Przedborski, S. (2001) · Current Opinion in Neurology · doi:10.1097/00019052-200108000-00009 · Cited by 326
Self-citationBurnstine, T. H. (1988) · Neurology · doi:10.1212/wnl.38.8.1337 · Cited by 323
Teismann, P., & Ferger, B. (2001) · Synapse · doi:10.1002/1098-2396(200102)39:2<167::aid-syn8>3.0.co;2-u · Cited by 306
Self-citationMPTP Toxicity: Implications for Research in Parkinson's Disease
Kopin, I. J., & Markey, S. P. (1988) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.11.030188.000501 · Cited by 295
Hökfelt, T., & Ungerstedt, U. (1973) · Brain Research · doi:10.1016/0006-8993(73)90791-9 · Cited by 292
Kohutnicka, M., Lewandowska, E., Kurkowska-Jastrzębska, I., Członkowski, A., & Członkowska, A. (1998) · Immunopharmacology · doi:10.1016/s0162-3109(98)00022-8 · Cited by 283
Mogi, M., Togari, A., Kondo, T., Mizuno, Y., Komure, O., Kuno, S., Ichinose, H., & Nagatsu, T. (2000) · Journal of Neural Transmission · doi:10.1007/s007020050028 · Cited by 282
Członkowska, A., Kohutnicka, M., Kurkowska-Jastrzębska, I., & Członkowski, A. (1996) · Neurodegeneration · doi:10.1006/neur.1996.0020 · Cited by 279
Levivier, M., Przedborski, S., Bencsics, C., & Kang, U. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-12-07810.1995 · Cited by 274 · cited 1×
“In experimental models of PD, 6-OHDA as well as MPTP, BDNF was able to confer a neuroprotective effect on dopaminergic neurons (Spina et al. 1992; Frim et al. 1994; Levivier et al. 1995), but data in human PD are still lacking.”
BackgroundHartmann, A., Troadec, J.-D., Hunot, S., Kikly, K., Faucheux, B. A., Mouatt-Prigent, A., Ruberg, M., Agid, Y., & Hirsch, E. C. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-07-02247.2001 · Cited by 270
Frim, D. M., Uhler, T. A., Galpern, W. R., Beal, M. F., Breakefield, X. O., & Isacson, O. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.5104 · Cited by 269 · cited 1×
“In experimental models of PD, 6-OHDA as well as MPTP, BDNF was able to confer a neuroprotective effect on dopaminergic neurons (Spina et al. 1992; Frim et al. 1994; Levivier et al. 1995), but data in human PD are still lacking.”
BackgroundIV. MPTP, MPP+ and mitochondrial function
Nicklas, W. J., Youngster, S. K., Kindt, M. V., & Heikkila, R. E. (1987) · Life Sciences · doi:10.1016/0024-3205(87)90299-2 · Cited by 257
Astrocytes protect neurons from nitric oxide toxicity by a glutathione‐dependent mechanism
Chen, Y., Vartiainen, N. E., Ying, W., Chan, P. H., Koistinaho, J., & Swanson, R. A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00374.x · Cited by 252
The parkinsonian toxin MPTP: action and mechanism
Przedborski, S., Jackson-Lewis, V., Djaldetti, R., Liberatore, G., Vila, M., Vukosavic, S., & Almer, G. (2000) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-2000-00132 · Cited by 252
Mitochondrial dysfunction in Parkinson's disease
Greenamyre, J. T., MacKenzie, G., Peng, T.-I., & Stephans, S. E. (1999) · Biochemical Society Symposia · doi:10.1042/bss0660085 · Cited by 248
Louis, E. D., Mayer, S. A., & Rowland, L. P. (2001) · Cited by 243
Ling, Z., Gayle, D. A., Ma, S. Y., Lipton, J. W., Tong, C. W., Hong, J., & Carvey, P. M. (2002) · Movement Disorders · doi:10.1002/mds.10078 · Cited by 241
Depino, A. M., Earl, C., Kaczmarczyk, E., Ferrari, C., Besedovsky, H., Del Rey, A., Pitossi, F. J., & Oertel, W. H. (2003) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2003.03014.x · Cited by 236
MPTP: current concepts and controversies.
Langston, J. W., & Irwin, I. (1986) · PubMed · Cited by 234
Age-Dependent Cognitive Deficits and Neuronal Apoptosis in Cyclooxygenase-2 Transgenic Mice
Andreasson, K. I., Savonenko, A., Vidensky, S., Goellner, J. J., Zhang, Y., Shaffer, A., Kaufmann, W. E., Worley, P. F., Isakson, P., & Markowska, A. L. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-20-08198.2001 · Cited by 231
Chapter 36: Astrocytes and Parkinson's disease
Forno, L. S., DeLanney, L. E., Irwin, I., Monte, D. D., & Langston, J. W. (1992) · Progress in Brain Research · doi:10.1016/s0079-6123(08)61770-7 · Cited by 230
Effects of 6-Hydroxydopamine on Noradrenaline-containing Neurones in the Rat Brain
URETSKY, N. J., & IVERSEN, L. L. (1969) · Nature · doi:10.1038/221557a0 · Cited by 225
Eberhardt, O., Coelln, R. V., Kügler, S., Lindenau, J., Rathke-Hartlieb, S., Gerhardt, E., Haid, S., Isenmann, S., Gravel, C., Srinivasan, A., et al. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09126.2000 · Cited by 209
Self-citationSphingomyelin breakdown and cell fate
TESTI, R. (1996) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(96)10056-6 · Cited by 208
Forno, L. S., DeLanney, L. E., Irwin, I., & Langston, J. W. (1993) · PubMed · Cited by 207
MPTP: Current Concepts and Controversies
Langston, J. W., & Irwin, I. (1986) · Clinical Neuropharmacology · doi:10.1097/00002826-198612000-00001 · Cited by 199
Kandel, E. R. (1970) · Scientific American · doi:10.1038/scientificamerican0770-57 · Cited by 198
Przedborski, S., Chen, Q., Vila, M., Giasson, B. I., Djaldatti, R., Vukosavic, S., Souza, J. M., Jackson‐Lewis, V., Lee, V. M. ‐., & Ischiropoulos, H. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00174.x · Cited by 190
Ferger, B., Leng, A., Mura, A., Hengerer, B., & Feldon, J. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02399.x · Cited by 186
Ferrer, I., Blanco, R., Carmona, M., Puig, B., Barrachina, M., Gómez, C., & Ambrosio, S. (2001) · Journal of Neural Transmission · doi:10.1007/s007020100015 · Cited by 172
Liu, J., Zhao, M. L., Brosnan, C. F., & Lee, S. C. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.8.3569 · Cited by 170
Microglial response to 6-hydroxydopamine-induced substantia nigra lesions
Akiyama, H., & McGeer, P. L. (1989) · Brain Research · doi:10.1016/0006-8993(89)90857-3 · Cited by 169
Evert, B. O., Vogt, I. R., Kindermann, C., Ozimek, L., de Vos, R. A. I., Brunt, E. R. P., Schmitt, I., Klockgether, T., & Wüllner, U. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-15-05389.2001 · Cited by 167
Neural transplantation — an experimental tool with clinical possibilities
Björklund, A. (1991) · Trends in Neurosciences · doi:10.1016/0166-2236(91)90154-m · Cited by 165
Changes in dopamine levels in the corpus striatum following lesions in the substantia nigra
Faull, R. L. M., & Laverty, R. (1969) · Experimental Neurology · doi:10.1016/0014-4886(69)90081-8 · Cited by 165
Feng, Z.-H., Wang, T.-G., Li, D.-D., Fung, P., Wilson, B. C., Liu, B., Ali, S. F., Langenbach, R., & Hong, J.-S. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00704-8 · Cited by 160
Ding, Y., Davisson, R. L., Hardy, D. O., Zhu, L.-J., Merrill, D. C., Catterall, J. F., & Sigmund, C. D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.44.28142 · Cited by 160
Moratalla, R., Quinn, B., DeLanney, L. E., Irwin, I., Langston, J. W., & Graybiel, A. M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.9.3859 · Cited by 158
Burke, R. E., Antonelli, M., & Sulzer, D. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71020517.x · Cited by 155
Tennyson, V. M., Heikkila, R. E., Mytilineou, C., COTE, L. J., & Cohen, G. (1974) · Brain Research · doi:10.1016/0006-8993(74)90617-9 · Cited by 155
Dopamine receptor interactions: some implications for the treatment of Parkinson's disease
Robertson, H. A. (1992) · Trends in Neurosciences · doi:10.1016/0166-2236(92)90034-6 · Cited by 154
Ijzermans, J. N. M., & Marquet, R. L. (1989) · Immunobiology · doi:10.1016/s0171-2985(89)80049-x · Cited by 153
Dose-dependent destruction of the coeruleus-cortical and nigral-striatal projections by MPTP
Seniuk, N. A., Tatton, W. G., & Greenwood, C. E. (1990) · Brain Research · doi:10.1016/0006-8993(90)91055-l · Cited by 153
Inducible Nitric-oxide Synthase and Nitric Oxide Production in Human Fetal Astrocytes and Microglia
Ding, M., Pierre, B. A. S., Parkinson, J. F., Medberry, P. S., Wong, J. L., Rogers, N. E., Ignarro, L. J., & Merrill, J. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.17.11327 · Cited by 153
Prostaglandin H Synthetase‐Mediated Metabolism of Dopamine: Implication for Parkinson's Disease
Mattammal, M. B., Strong, R., Lakshmi, V. M., Chung, H. D., & Stephenson, A. H. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64041645.x · Cited by 151
Heikkila, R. E., Sieber, B.-A., Manzino, L., & Sonsalla, P. K. (1989) · Molecular and Chemical Neuropathology · doi:10.1007/bf03159727 · Cited by 150
O'Callaghan, J. P., Miller, D. B., & Reinhard, J. F. (1990) · Brain Research · doi:10.1016/0006-8993(90)91526-m · Cited by 145
Declercq, W., Denecker, G., Fiers, W. C., & Vandenabeele, P. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.1.390 · Cited by 145
Nagata, K., Takei, N., Nakajima, K., Saitō, H., & Kohsaka, S. (1993) · Journal of Neuroscience Research · doi:10.1002/jnr.490340313 · Cited by 144
Muthane, U. B., Ramsay, K., Jiang, H., Jackson-Lewis, V. R., Donaldson, D. M., Fernando, S., Ferreira, M., & Przedborski, S. (1994) · Experimental Neurology · doi:10.1006/exnr.1994.1058 · Cited by 143
Peterson, P. K., Hu, S., Anderson, W. R., & Chao, C. C. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/170.2.457 · Cited by 143
Neve, K. A., Kozlowski, M. R., & Marshall, J. F. (1982) · Brain Research · doi:10.1016/0006-8993(82)90901-5 · Cited by 138
Bessler, H., Djaldetti, R., Salman, H., Bergman, M., & Djaldetti, M. (1999) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(99)80079-1 · Cited by 135
McNaught, K. S. P., & Jenner, P. G. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0732469.x · Cited by 132
Javoy-Agid, F., Sotelo, C., Herbet, A., & Agid, Y. (1976) · Brain Research · doi:10.1016/0006-8993(76)90877-5 · Cited by 132
Injection of 6-hydroxydopamine in the substantia nigra of the rat. I. Morphological study
Sotelo, C., Javoy-Agid, F., Agid, Y., & Glowinski, J. (1973) · Brain Research · doi:10.1016/0006-8993(73)90001-2 · Cited by 131
Hayley, S. P., Crocker, S. J., Smith, P. D., Shree, T., Jackson-Lewis, V. R., Przedborski, S., Mount, M., Slack, R. S., Anisman, H., & Park, D. S. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.4564-03.2004 · Cited by 125
Dopamine Cell Replacement: Parkinson's Disease
Yurek, D. M., & Sladek, J. R. (1990) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.13.030190.002215 · Cited by 123
Mogi, M., Harada, M., Kondo, T., Riederer, P. F., & Nagatsu, T. (1995) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02252965 · Cited by 119
Strömberg, I., Björklund, H., Dahl, D. R., JONSSON, G., Sundström, E., & Olson, L. (1986) · Brain Research Bulletin · doi:10.1016/0361-9230(86)90119-x · Cited by 116
Exaggerated astrocyte reactivity after nigrostriatal deafferentation in the aged rat
Gordon, M. N., Schreier, W. A., Ou, X., Holcomb, L. A., & Morgan, D. (1997) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19971110)388:1<106::aid-cne7>3.0.co;2-5 · Cited by 111
Jiang, H., Jackson-Lewis, V. R., Muthane, U. B., Dollison, A. M., Ferreira, M., Espinosa, A., Parsons, B., & Przedborski, S. (1993) · Brain Research · doi:10.1016/0006-8993(93)90925-d · Cited by 109
Role of Cyclooxygenase-2 in Neuronal Cell Cycle Activity and Glutamate-Mediated Excitotoxicity
Mirjany, M., Ho, L., & Pasinetti, G. M. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.2.494 · Cited by 109
Postencephalitic parkinsonism – a review
Casals, J., Elizan, T. S., & Yahr, M. D. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050086 · Cited by 108
NF-κB activation and IκBα dynamism involved in iNOS and chemokine induction in astroglial cells
Nomura, Y. (2001) · Life Sciences · doi:10.1016/s0024-3205(01)00967-5 · Cited by 104
Saura, J., Petegnief, V., Wu, X., Liang, Y., & Paul, S. M. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01788.x · Cited by 99
Rodrigues, R. W. P., Gomide, V. C., & Chadi, G. (2001) · International Journal of Neuroscience · doi:10.3109/00207450108986528 · Cited by 91
Toxin-Induced Models of Neurological Disorders
Woodruff, M. L., & Nonneman, A. J. (1994) · Springer eBooks · doi:10.1007/978-1-4899-1447-7 · Cited by 82
Trauma as an etiology of parkinsonism: A historical review of the concept
Factor, S. A., Sanchez‐Ramos, J., & Weiner, W. J. (1988) · Movement Disorders · doi:10.1002/mds.870030105 · Cited by 81
Lack of acquisition in dopamine denervated animals tested in an underwater y-maze
Ranje, C., & Ungerstedt, U. (1977) · Brain Research · doi:10.1016/0006-8993(77)90928-3 · Cited by 80
Free Radicals in Brain Pathophysiology
Poli, G. (2000) · CRC Press eBooks · doi:10.1201/9781482270167 · Cited by 73
Sortwell, C. E., Daley, B. F., Pitzer, M. R., McGuire, S. O., Sladek, J. R., & Collier, T. J. (2000) · The Journal of Comparative Neurology · doi:10.1002/1096-9861(20001009)426:1<143::aid-cne10>3.0.co;2-8 · Cited by 67
Sheng, J. G., Shirabe, S., Nishiyama, N., & Schwartz, J. P. (1993) · Experimental Brain Research · doi:10.1007/bf00227138 · Cited by 65
Wakabayashi, K., Fukushima, T., Koide, R., Horikawa, Y., Hasegawa, M., Watanabe, Y., Noda, T., Eguchi, I., Morita, T., Yoshimoto, M., et al. (2000) · Acta Neuropathologica · doi:10.1007/s004010050049 · Cited by 64
Lucas, R., Garcia, I., Donati, Y. R. A., Hribar, M., Mandriota, S. J., Giroud, C., Buurman, W. A., Fransen, L., Suter, P. M., Núñez, G., et al. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199811)28:11<3577::aid-immu3577>3.0.co;2-# · Cited by 62
Janabi, N., Chabrier, S., & Tardieu, M. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.5.2129 · Cited by 60
FADD: A link between TNF family receptors and caspases in Parkinson’s disease
Hartmann, A., Prigent, A., Faucheux, B. A., Agid, Y., & Hirsch, É. C. (2002) · Neurology · doi:10.1212/wnl.58.2.308 · Cited by 60
Saura, J., Parés, M., Bové, J., Pezzi, S., Alberch, J., Marı́n, C., TOLOSA, E. S., & Martı́, M. J. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01676.x · Cited by 58
Phagocytic cell function in aged subjects
Mège, J. L., Capo, C., Michel, B. F., Gastaut, J. L., & Bongrand, P. (1988) · Neurobiology of Aging · doi:10.1016/s0197-4580(88)80054-x · Cited by 55
Benazzouz, A., Piallat, B., Ni, Z., Koudsié, A., Pollak, P., & Benabid, A. (2000) · Cell Transplantation · doi:10.1177/096368970000900207 · Cited by 55
Adverse Effects of Levodopa in Parkinson’s Disease
Fahn, S. (1989) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-73899-9_14 · Cited by 52
Glial cell participation in the degeneration of dopaminergic neurons in Parkinson's disease.
Hirsch, É. C., Hunot, S., Damier, P., Brugg, B., Faucheux, B. A., Michel, P. P., Ruberg, M., Muriel, M., Prigent, A., & Agid, Y. (1999) · PubMed · Cited by 52
Glial gene expression during aging in rat striatum and in long-term responses to 6-OHDA lesions
Pasinetti, G. M., Hassler, M., Stone, D., & Finch, C. E. (1999) · Synapse · doi:10.1002/(sici)1098-2396(19990315)31:4<278::aid-syn5>3.0.co;2-0 · Cited by 50
Mitochondria1 involvement in Parkinson's disease: The controversy continues
DiMauro, S. (1993) · Neurology · doi:10.1212/wnl.43.11.2170 · Cited by 50
Gluck, M. R., Youngster, S. K., Ramsay, R. R., Singer, T. P., & Nicklas, W. J. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63020655.x · Cited by 40
Törnwall, M., & Männistö, P. T. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90623-p · Cited by 39
Free radical and nitric oxide toxicity in Parkinson's disease.
Przedborski, S., Jackson-Lewis, V. R., Vila, M., et al. (2003) · PubMed · Cited by 36
Nuclear factor-κB activation is not involved in a MPTP model of Parkinson's disease
Teismann, P., Schwaninger, M., Weih, F., & Ferger, B. (2001) · Neuroreport · doi:10.1097/00001756-200104170-00037 · Cited by 34
Self-citationGrowth Promoting and Inhibitory Effects of Glial Cells in the Mammalian Nervous System
Hirsch, S., & Bähr, M. (1999) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4685-6_16 · Cited by 27
6-Hydroxydopamine Lesions of Nigrostriatal Neurons as an Animal Model of Parkinson’s Disease
Reading, P., & Dunnett, S. B. (1994) · Springer eBooks · doi:10.1007/978-1-4899-1447-7_4 · Cited by 18
Gp, W., & Knott, C. (1999) · PubMed · Cited by 13
Langston, J. W., Forno, L. S., Tetrud, J., Reeves, A. G., Kaplan, J. A., & Karluk, D. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199910)46:4 · Cited by 1
Kordower (1999) · doi:10.1002/1531-8249(199909)46:3
Cited by
Ageing and neuronal vulnerability
Mattson, M. P., & Magnus, T. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1886 · Cited by 957
Saijo, K., Winner, B., Carson, C. T., Collier, J. G., Boyer, L., Rosenfeld, M. G., Gage, F. H., & Glass, C. K. (2009) · Cell · doi:10.1016/j.cell.2009.01.038 · Cited by 957
Mechanisms of Disease: astrocytes in neurodegenerative disease
Maragakis, N. J., & Rothstein, J. D. (2006) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0355 · Cited by 812
Glial reactions in Parkinson's disease
McGeer, P. L., & McGeer, E. G. (2008) · Movement Disorders · doi:10.1002/mds.21751 · Cited by 701
The Drosophila Cell Corpse Engulfment Receptor Draper Mediates Glial Clearance of Severed Axons
MacDonald, J. M., Beach, M. G., Porpiglia, E., Sheehan, A. E., Watts, R. J., & Freeman, M. R. (2006) · Neuron · doi:10.1016/j.neuron.2006.04.028 · Cited by 523
Metadata
- Authors
- Teismann, P., & Schulz, J. B.
- Venue
- Cell and Tissue Research
- Published
- 2004-08-24
- Volume
- 318
- Issue
- 1
- Pages
- 149-161
- ISSN
- 0302-766X (ISSN-L)
- 1432-0878
- OpenAlex
- W1994004433
- Cited by
- 363
- References
- 165
- FWCI
- 13.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.